114 related articles for article (PubMed ID: 30197351)
1. CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma: Is it associated with poor outcome?
Pamuk GE; Tozkır H; Uyanık MS; Gurkan H; Duymaz J; Pamuk ON
J Cancer Res Ther; 2018; 14(5):1075-1078. PubMed ID: 30197351
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
3. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
Zhang Y; Chen MB; Zhou XY; Hong XN
PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
[TBL] [Abstract][Full Text] [Related]
4. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
Pamuk GE; Tozkir H; Uyanik MS; Gurkan H; Duymaz J; Pamuk ON
Leuk Lymphoma; 2015; 56(10):2902-7. PubMed ID: 25699652
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.
Gao L; Feng Z; Li Q; Li L; Chen L; Xiao T
Tumour Biol; 2014 Apr; 35(4):2997-3002. PubMed ID: 24248544
[TBL] [Abstract][Full Text] [Related]
8. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
9. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
Tawfeek GA; Alhassanin S
Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
[TBL] [Abstract][Full Text] [Related]
11. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
12. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Tong D; Cha Z; Bai J
Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
[TBL] [Abstract][Full Text] [Related]
13. Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma.
Diao LP; Yu XM; Gao YH; Li Y; Liu HS; Liu LH; Zhou RM; Wang N; Wu LL; Wang SJ
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1473-81. PubMed ID: 19649652
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
15. [Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma].
Song B; Zhu JY; Liu J; Wang ZH; Shi Y; Lü LY; Zheng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):97-100. PubMed ID: 18315909
[TBL] [Abstract][Full Text] [Related]
16. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
17. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
18. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
[TBL] [Abstract][Full Text] [Related]
19. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
Warzocha K; Ribeiro P; Bienvenu J; Roy P; Charlot C; Rigal D; Coiffier B; Salles G
Blood; 1998 May; 91(10):3574-81. PubMed ID: 9572991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
